Franklin Resources Portfolio holdings
Franklin Resources, Inc., commonly known as Franklin Templeton, was founded in 1947 by Rupert H. Johnson, Sr., and is headquartered in San Mateo, California, operating as a global investment management firm managing hundreds of billions in assets. The company offers a wide range of investment products, including mutual funds, ETFs, fixed-income portfolios, and alternative investments, serving individual investors, financial advisors, and institutions across over 150 countries. Known for its acquisition-driven growth—such as the 1992 purchase of Templeton Investments and the 2020 addition of Legg Mason—Franklin Templeton combines diverse strategies under a single brand, emphasizing both active management and income-focused solutions like its flagship Franklin Income Fund. With a reputation for adaptability and a client-centric approach, it remains a major player in the global asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Accenture
ACN
|
+$1.28B |
| 2 |
Allstate
ALL
|
+$839M |
| 3 |
Cisco
CSCO
|
+$644M |
| 4 |
Seagate
STX
|
+$636M |
| 5 |
Eli Lilly
LLY
|
+$507M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Scientific
BSX
|
+$915M |
| 2 |
NVIDIA
NVDA
|
+$820M |
| 3 |
Oracle
ORCL
|
+$694M |
| 4 |
Bank of America
BAC
|
+$682M |
| 5 |
Advanced Micro Devices
AMD
|
+$624M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.89% |
| 2 | Financials | 13.48% |
| 3 | Healthcare | 13.1% |
| 4 | Industrials | 9.44% |
| 5 | Consumer Discretionary | 8.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
701
Aaon
AAON
$8.41B
| $33.5M | 0.01% |
429,195
+83,374
| +24% | +$8.6M |
|
702
Invesco S&P 500 High Dividend Low Volatility ETF
SPHD
$3.36B
| $33.5M | 0.01% |
667,317
+7,703
| +1% | +$379K |
|
703
Assured Guaranty
AGO
$3.78B
| $33.4M | 0.01% |
379,200
-74,975
| -17% | -$6.72M |
|
|
BASE
704
DELISTED
Couchbase
BASE
| $32.9M | 0.01% |
2,092,063
+2,959
| +0.1% | +$49K |
|
705
Apogee Therapeutics
APGE
$10.2B
| $32.7M | 0.01% |
876,076
+9,888
| +1% | +$382K |
|
706
Delta Air Lines
DAL
$55.9B
| $32.7M | 0.01% |
750,049
-53,109
| -7% | -$3.15M |
|
707
Vanguard Growth ETF
VUG
$216B
| $32.7M | 0.01% |
528,306
-4,014
| -0.8% | -$271K |
|
708
Liberty Global Class A
LBTYA
$3.31B
| $32.6M | 0.01% |
2,834,282
+174,552
| +7% | +$2.03M |
|
|
ALEX
709
DELISTED
Alexander & Baldwin
ALEX
| $32.6M | 0.01% |
1,891,149
-947,266
| -33% | -$16.7M |
|
710
ADMA Biologics
ADMA
$1.92B
| $32.4M | 0.01% |
1,633,730
+1,306,719
| +400% | +$22.6M |
|
711
JPMorgan Ultra-Short Income ETF
JPST
$40B
| $32.4M | 0.01% |
639,740
+153,932
| +32% | +$7.78M |
|
712
Bank of Montreal
BMO
$125B
| $32.4M | 0.01% |
338,918
+4,585
| +1% | +$453K |
|
713
Crinetics Pharmaceuticals
CRNX
$8.86B
| $32.3M | 0.01% |
963,281
-628,385
| -39% | -$23.5M |
|
|
CSW
714
CSW Industrials
CSW
$4.71B
| $32.3M | 0.01% |
110,808
+8,350
| +8% | +$2.71M |
|
715
CG Oncology
CGON
$6.11B
| $32.3M | 0.01% |
1,318,934
+43,043
| +3% | +$1.21M |
|
716
UMB Financial
UMBF
$10.7B
| $32.1M | 0.01% |
317,105
+8,561
| +3% | +$944K |
|
717
Janux Therapeutics
JANX
$935M
| $32M | 0.01% |
1,186,479
+689,192
| +139% | +$26M |
|
|
VZLA
718
Vizsla Silver
VZLA
$1.16B
| $32M | 0.01% |
13,985,000
-2,132,500
| -13% | -$4.48M |
|
|
DAWN
719
DELISTED
Day One Biopharmaceuticals
DAWN
| $31.9M | 0.01% |
4,018,370
+135,418
| +3% | +$1.46M |
|
720
Camden Property Trust
CPT
$11.3B
| $31.8M | 0.01% |
259,698
+10,452
| +4% | +$1.23M |
|
721
HNI Corp
HNI
$3B
| $31.7M | 0.01% |
715,603
-1,007,038
| -58% | -$47.6M |
|
722
Patrick Industries
PATK
$2.8B
| $31.7M | 0.01% |
374,314
+112,497
| +43% | +$10.1M |
|
723
Alaska Air
ALK
$5.15B
| $31.6M | 0.01% |
642,517
+2,509
| +0.4% | +$165K |
|
724
Cincinnati Financial
CINF
$28.3B
| $31.6M | 0.01% |
213,691
+63,176
| +42% | +$8.89M |
|
725
Clorox
CLX
$11.6B
| $31.3M | 0.01% |
212,804
+24,177
| +13% | +$3.69M |
|
Similar funds
Franklin Resources's Q1 2025 Portfolio in Review
As of Q1 2025, Franklin Resources held 3,109 positions worth $348B, down 3.5% from $360B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Franklin Resources's Q1 2025 filing shows 194 new, 1,450 increased, 990 reduced and 148 closed positions. Its largest new stake was KKR & Co 6.25% Series D Preferred Stock: 1,295,000 shares worth $64M. The largest sale was Boston Scientific, an estimated $915M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 27% a quarter earlier, followed by Financials and Healthcare.
- Franklin Resources's largest Q1 2025 buy was KKR & Co 6.25% Series D Preferred Stock: 1,295,000 shares worth $64M.
- Franklin Resources added most to Accenture in Q1 2025, an estimated $1.28B increase.
- Franklin Resources's biggest Q1 2025 reduction was Boston Scientific, cutting an estimated $915M.
- Franklin Resources fully exited Hyatt Hotels in Q1 2025, selling an estimated $305M.
- Franklin Resources's ten largest holdings make up 21% of its $348B portfolio in Q1 2025.
- Franklin Resources opened 194 new positions and closed 148 in Q1 2025.
- Franklin Resources's portfolio value fell 3.5% quarter-over-quarter to $348B.
Based on Franklin Resources's 13F filing for Q1 2025, filed 13 May 2025.